These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8391950

  • 1. Effects of an orally active vasopressin V1 receptor antagonist.
    Burrell LM, Phillips PA, Stephenson J, Risvanis J, Hutchins AM, Johnston CI.
    Clin Exp Pharmacol Physiol; 1993 May; 20(5):388-91. PubMed ID: 8391950
    [Abstract] [Full Text] [Related]

  • 2. Characterization of a novel non-peptide vasopressin V1 receptor antagonist (OPC-21268) in the rat.
    Burrell LM, Phillips PA, Stephenson J, Risvanis J, Hutchins AM, Johnston CI.
    J Endocrinol; 1993 Aug; 138(2):259-66. PubMed ID: 8228734
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Blocking effects of V1 (OPC-21268) and V2 (OPC-31260) antagonists on the negative inotropic response to vasopressin in isolated dog heart preparations.
    Furukawa Y, Takayama S, Ren LM, Sawaki S, Inoue Y, Chiba S.
    J Pharmacol Exp Ther; 1992 Nov; 263(2):627-31. PubMed ID: 1331408
    [Abstract] [Full Text] [Related]

  • 11. Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist.
    Yamamura Y, Ogawa H, Yamashita H, Chihara T, Miyamoto H, Nakamura S, Onogawa T, Yamashita T, Hosokawa T, Mori T.
    Br J Pharmacol; 1992 Apr; 105(4):787-91. PubMed ID: 1387020
    [Abstract] [Full Text] [Related]

  • 12. Distinct mechanisms of action of V1 antagonists OPC-21268 and [d(CH2)5Tyr(Me)AVP] in mesangial cells.
    Jamil KM, Watanabe T, Nakao A, Okuda T, Kurokawa K.
    Biochem Biophys Res Commun; 1993 Jun 15; 193(2):738-43. PubMed ID: 8390252
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Arg8]vasopressin-induced responses of the human isolated coronary artery: effects of non-peptide receptor antagonists.
    Bax WA, Van der Graaf PH, Stam WB, Bos E, Nisato D, Saxena PR.
    Eur J Pharmacol; 1995 Oct 16; 285(2):199-202. PubMed ID: 8566139
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.